SCHEMBL12637482

SCHEMBL12637482

CN(C)c1nc2c(-c3ccc4ccccc4c3)cccc2s1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 2/20 0.39
▸ RAB9A P51151 2/20 0.39
▸ TP53 P04637 1/20 0.39
▸ HPGD P15428 1/20 0.39
▸ NFKB1 P19838 1/20 0.39
▸ NFKB2 Q00653 1/20 0.39
▸ RELA Q04206 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ GSTP1 P09211 1/20 0.39
▸ S1PR4 O95977 4/20 0.38
▸ S1PR5 Q9H228 4/20 0.38
▸ CSNK1D P48730 1/20 0.38
▸ MAPK11 Q15759 1/20 0.38
▸ MAPK14 Q16539 1/20 0.38
▸ HDAC4 P56524 1/20 0.37
▸ HDAC2 Q92769 1/20 0.37
▸ HDAC8 Q9BY41 1/20 0.37
▸ SLC6A2 P23975 1/20 0.37
▸ SLC6A4 P31645 1/20 0.37
▸ SLC6A3 Q01959 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12637475 0.84 SMN1; SMN2 (0.43) NPC1RAB9ATP53HPGDNFKB1
SCHEMBL12637481 0.84 SMN1; SMN2 (0.45) NPC1RAB9ATP53HPGDNFKB1
SCHEMBL12637468 0.84 SMN1; SMN2 (0.47) NPC1RAB9ATP53HPGDNFKB1
SCHEMBL12637466 0.82 ENPP1 (0.44) NPC1RAB9ATP53HPGDNFKB1
SCHEMBL12637464 0.81 ENPP1 (0.42) NPC1RAB9ATP53HPGDNFKB1
SCHEMBL12637474 0.80 SMN1; SMN2 (0.35) NPC1RAB9ATP53HPGDNFKB1
SCHEMBL12637476 0.78 HPGD (0.42) NPC1RAB9ATP53HPGDNFKB1
SCHEMBL12637463 0.77 ENPP1 (0.41) NPC1RAB9ATP53HPGDNFKB1
SCHEMBL12637467 0.77 SMN1; SMN2 (0.43) NPC1RAB9ATP53HPGDNFKB1
SCHEMBL12637488 0.73 HPGD (0.40) NPC1RAB9ATP53HPGDNFKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7939669-B2 Metallic compound and organic electroluminescence device comprising the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2011-05-10 — — US disclosed
US-7939669-B2 Metallic compound and organic electroluminescence device comprising the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2011-05-10 — — US disclosed
US-20090306395-A1 METALLIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE SAME SAMSUNG ELECTRONICS CO., LTD., (KR) 2009-12-10 — — US disclosed
US-20090306395-A1 METALLIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE SAME SAMSUNG ELECTRONICS CO., LTD., (KR) 2009-12-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090306395-A1 METALLIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE SAME SCO2, RPS4Y1, RER1 NPC1 2314/4885RAB9A 1046/4885TP53 3658/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback